Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20-02-2018

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

golden_brown / iStockphoto.com

Trade associations Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization (BIO) have called for Malaysia to be placed on the US Trade Representative’s (USTR) watch list in its “2018 Special 301 Report”. 


PhRMA, BIO, USTR, innovation, patent, Special 301 Report, medicines, IP protection, market access, barriers, biopharmaceuticals

LSIPR